Literature DB >> 30539468

An Efficient Method to Generate Monoclonal Antibodies from Human B Cells.

Jenna J Guthmiller1, Haley L Dugan2, Karlynn E Neu1,2, Linda Yu-Ling Lan2, Patrick C Wilson3,4.   

Abstract

In the age of personalized medicine, an efficient method to generate monoclonal antibodies (mAbs) is essential for biomedical and immunotherapeutic research. Numerous aspects of basic B-cell biology can be studied at the monoclonal level, including B-cell development, antibody responses to infection or vaccination, and autoimmune responses. Single-cell B-cell receptor cloning allows for the rapid generation of antigen-specific mAbs in a matter of several weeks. In this chapter, we provide an efficient method to generate mAbs from peripheral blood plasmablasts and memory B cells induced by infection and vaccination. Additionally, we provide a protocol on how to optimize single-cell B-cell sorting for both single-cell B-cell receptor cloning and single-cell RNA-sequencing, for the application of studying B-cell specificity and function (spec-seq). This protocol can be easily adapted for other B-cell populations, B cells in tissues, and B cells from other organisms.

Entities:  

Keywords:  B-cell receptor; Cloning; Humoral immunity; Infection; Memory B-cell; Monoclonal antibody; Plasmablast; Single-cell RNA-sequencing; Spec-seq; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 30539468     DOI: 10.1007/978-1-4939-8958-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.

Authors:  Yuanyuan Liu; Zhen Song; Shuang Ge; Jinyong Zhang; Limin Xu; Feng Yang; Dongshui Lu; Ping Luo; Jiang Gu; Quanming Zou; Hao Zeng
Journal:  Hum Vaccin Immunother       Date:  2020-04-10       Impact factor: 3.452

2.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.

Authors:  Haley L Dugan; Jenna J Guthmiller; Philip Arevalo; Min Huang; Yao-Qing Chen; Karlynn E Neu; Carole Henry; Nai-Ying Zheng; Linda Yu-Ling Lan; Micah E Tepora; Olivia Stovicek; Dalia Bitar; Anna-Karin E Palm; Christopher T Stamper; Siriruk Changrob; Henry A Utset; Lynda Coughlan; Florian Krammer; Sarah Cobey; Patrick C Wilson
Journal:  Sci Transl Med       Date:  2020-12-09       Impact factor: 17.956

3.  Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.

Authors:  Nada Abbadi; Kaito Nagashima; Alma Pena-Briseno; Ted M Ross; Jarrod J Mousa
Journal:  J Virol       Date:  2022-08-02       Impact factor: 6.549

4.  Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens.

Authors:  Lei Li; Siriruk Changrob; Yanbin Fu; Olivia Stovicek; Jenna J Guthmiller; Joshua J C McGrath; Haley L Dugan; Christopher T Stamper; Nai-Ying Zheng; Min Huang; Patrick C Wilson
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 13.994

5.  Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.

Authors:  Alec W Freyn; Julianna Han; Jenna J Guthmiller; Mark J Bailey; Karlynn Neu; Hannah L Turner; Victoria C Rosado; Veronika Chromikova; Min Huang; Shirin Strohmeier; Sean T H Liu; Viviana Simon; Florian Krammer; Andrew B Ward; Peter Palese; Patrick C Wilson; Raffael Nachbagauer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

Review 6.  Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic.

Authors:  Yaping Sun; Mitchell Ho
Journal:  Antib Ther       Date:  2020-11-24

7.  Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.

Authors:  Seth J Zost; Pavlo Gilchuk; Rita E Chen; James Brett Case; Joseph X Reidy; Andrew Trivette; Rachel S Nargi; Rachel E Sutton; Naveenchandra Suryadevara; Elaine C Chen; Elad Binshtein; Swathi Shrihari; Mario Ostrowski; Helen Y Chu; Jonathan E Didier; Keith W MacRenaris; Taylor Jones; Samuel Day; Luke Myers; F Eun-Hyung Lee; Doan C Nguyen; Ignacio Sanz; David R Martinez; Paul W Rothlauf; Louis-Marie Bloyet; Sean P J Whelan; Ralph S Baric; Larissa B Thackray; Michael S Diamond; Robert H Carnahan; James E Crowe
Journal:  Nat Med       Date:  2020-07-10       Impact factor: 87.241

8.  An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.

Authors:  Jenna J Guthmiller; Henry A Utset; Carole Henry; Lei Li; Nai-Ying Zheng; Weina Sun; Marcos Costa Vieira; Seth Zost; Min Huang; Scott E Hensley; Sarah Cobey; Peter Palese; Patrick C Wilson
Journal:  mBio       Date:  2021-06-15       Impact factor: 7.867

9.  Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics.

Authors:  Pavlo Gilchuk; Robin G Bombardi; Jesse H Erasmus; Qing Tan; Rachel Nargi; Cinque Soto; Peter Abbink; Todd J Suscovich; Lorellin A Durnell; Amit Khandhar; Jacob Archer; Jenny Liang; Mallorie E Fouch; Edgar Davidson; Benjamin J Doranz; Taylor Jones; Elise Larson; Stacey Ertel; Brian Granger; Jasmine Fuerte-Stone; Vicky Roy; Thomas Broge; Thomas C Linnekin; Caitlyn H Linde; Matthew J Gorman; Joseph Nkolola; Galit Alter; Steven G Reed; Dan H Barouch; Michael S Diamond; James E Crowe; Neal Van Hoeven; Larissa B Thackray; Robert H Carnahan
Journal:  Nat Biomed Eng       Date:  2020-08-03       Impact factor: 29.234

10.  Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2.

Authors:  Patrick Wilson; Christopher Stamper; Haley Dugan; Lei Li; Nicholas Asby; Peter Halfmann; Jenna Guthmiller; Nai-Ying Zheng; Min Huang; Olivia Stovicek; Jiaolong Wang; Maria Lucia Madariaga; Kumaran Shanmugarajah; Maud Jansen; Fatima Amanat; Isabelle Stewart; Siriruk Changrob; Henry Utset; Jun Huang; Christopher Nelson; Ya-Nan Dai; Paige Hall; Robert Jedrzejczak; Andrzej Joachimiak; Florian Krammer; Daved Fremont; Yoshihiro Kawaoka
Journal:  Res Sq       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.